Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
Research

Spatiotemporal Dynamics of Sporadic Shiga Toxin–Producing Escherichia coli Enteritis, Ireland, 2013–2017

Eimear Cleary1, Martin Boudou1, Patricia Garvey, Coilin Oh Aiseadha, Paul McKeown, Jean O’DwyerComments to Author , and Paul HyndsComments to Author 
Author affiliations: Technological University Dublin, Dublin, Ireland (E. Cleary, M. Boudou, P. Hynds); Health Protection Surveillance Centre, Dublin (P. Garvey, P. McKeown); Steeven’s Hospital, Dublin (C. Oh’Aiseadha); University College Cork, Cork, Ireland (J. O’Dwyer)

Main Article

Table 1

Confirmed sporadic verocytotoxin-producing Escherichia coli infections in Ireland, 2013–2017*

Characteristic VTEC O157 VTEC 026 Other serogroups Not serotyped/ungroupable
Total
 668
 714
 724
 649
Age
<5 y 231 (34.6) 431 (60.4) 255 (35.2) 184 (28.4)
6–64 y 373 (55.8) 232 (32.5) 314 (43.4) 273 (42.1)
>65 y
 64 (9.6)
 51 (7.1)
 155 (21.4)
 192 (29.6)
Setting
Urban 288 (43.1) 278 (38.9) 329 (45.4) 309 (47.6)
Rural 380 (56.9) 436 (61.1) 395 (54.6) 340 (52.4)

*Values are no. (%) except as indicated. Percentages refer to VTEC serotype column totals vs case age range and Central Statistics Office Urban/Rural classification. VTEC, verocytotoxin-producing Escherichia coli.

Main Article

1These first authors contributed equally to this article.

Page created: July 15, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external